Lawmakers debated innovation, competition, and biosimilar access as the Supreme Court weighed in.
Lawmakers examined foreign manufacturing, patient safety, and FDA oversight gaps.
From Medicaid work requirements to infectious disease preparedness, here's what you need to know.
The latest federal, state, and industry developments shaping healthcare policy in Washington and beyond.
MAHA Momentum, Maternal Health, and FDA Scrutiny Lead the Week
The key pressures fueling higher bills and premiums
Drug pricing, behavioral health, and oversight take center stage
Hospice scams, fake providers, and what’s driving it.
Key takeaways on costs, vaccines, and coverage debates
Budget battles, vaccines, and public health priorities
Innovation vs. affordability—here’s what’s at stake.
Reauthorizations aim to strengthen public health systems.
